Viela Bio's Series A Round

Viela Bio raised a round of funding on February 28, 2018.

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the r…

Articles about Viela Bio's Series A Round: